ロード中...
Carboxyamidotriazole exerts anti-inflammatory activity in lipopolysaccharide-induced RAW264.7 macrophages by inhibiting NF-κB and MAPKs pathways
Carboxyamidotriazole (CAI), originally developed as a non-cytotoxic anti-cancer drug, was shown to have anti-inflammatory activity according to recent studies in a number of animal models of inflammation. However, its mechanism of action has not been characterized. Therefore, the present study was p...
保存先:
| 出版年: | Exp Ther Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7388320/ https://ncbi.nlm.nih.gov/pubmed/32742379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.8889 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|